DYTN

Across TCGA pan-cancer cohorts, DYTN RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of DYTN’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where DYTN RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DYTN is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.

HNSC, COAD, and LUAD are the cancer types where DYTN tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DYTN RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.014	.002	8	view →
COAD	Female	III,IV	−0.030	.007	5	view →
LUAD	Female	All	−0.030	.002	5	view →
BLCA	All	All	+0.014	.008	5	view →
PRAD	All	All	+0.328	.004	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

DYTN–HNSC

Open the HNSC breakdown →